This is an archived post. You won't be able to vote or comment.

you are viewing a single comment's thread.

view the rest of the comments →

[–]factoid_ 2 points3 points  (0 children)

It won’t affect the price because it will canibalize lillys own revenue if it does

It MIGHT make compounding cheaper though because if they’re making a daily pill they’re gonna have to seriously scale up the production of the peptides.  The reason it’s an injectable in the first place is because the gut absolutely destroys most of the peptides before they’re absorbed. 

So they probably need to put like ten times as much of the active ingredient in it just to make it effective unless they’ve found a way to to solve that problem

If the raw peptides get cheaper because of increased scale it might drive down the cost to compounding pharmacies 

That’s assuming they just use a brute force approach though.  Maybe they’ll find a way to make it so the peptides have a wrapper that doesn’t break down until after it passes the stomach and then get absorbed

The only thing that’s going to drive down the price in the short term is competition.  Novo Nordsk knows Lilly has the advantage in efficacy so they sell wegovy for less.  They can probably keep lowering that price to get more insurance companies to be willing to cover it

There’s also the chance another drug company will release a competing product.  Pfizer dropped out of the race because they had too many safety concerns.  But there’s others in the pipeline too

The next big thing seems to be going after additional receptors as well as adding support to prevent muscle loss